[1] Hawkes CA, Ng V, McLaurin (2009) Small Molecule Inhibitors of A beta-Aggregation and Neurotoxicity. J. Drug Dev. Res 70: 111-124
[2] Re F, Airoldi C, Zona C, Masserini M, La Ferla B, Quattrocchi N, Nicotra F (2010) Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease. Curr. Med. Chem 17: 2990-3006
[3] Ferrão-Gonzales AD, Robbs BK, Moreau VH, Ferreira A, Juliano L, Valente AP, Almeida FCL, Silva JL, Foguel DJ (2005) Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species. Biol. Chem 280: 34747-34754
[4] Howlett DR, Perry A, Godfrey F, Swatton JE, Jennings KH, Spitzfaden C, Wadsworth H, Wood SJ, Markwell RE (1999) Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans Biochem. J 340: 283-289
[5] Soto-Ortega DD, Murphy BP, Gonzalez-Velasquez FJ, Wilson KA, Xie F, Wang Q, Moss MA (2011) Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center. Bioorg. Med. Chem 19: 2596-2602
[6] Moore SA, Huckerby TN, Gibson GL, Fullwood NJ, Turnbull S, Tabner BJ, El-Agnaf OM, Allsop D (2004) Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity. Biochemistry (2004) 43: 819-826
[7] Johnson SM, Connelly S, Wilson IA, Kelly JW (2008) Towards optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies. J Med Chem. 51: 6348-6358
[8] Novick PA, Lopes DH, Branson KM, Esteras-Chopo A, Graef IA, Bitan G, Pande VS (2012) Design of β-amyloid aggregation inhibitors from a predicted structural motif J Med Chem 55: 3002-3010
[9] Reinke AA, Gestwicki JE (2007) Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des 70: 206-215
[10] Stevens CB, Hanna JM JR. Lammi RK (2013) Synthesis of tetrahydroxybiphenyls and tetrahydroxyterphenyls and their evaluation as amyloid-β aggregation inhibitors. Bioorg Med. Chem. Lett 23: 1703–1706
[11] Buchete NV, Tycko R, Hummer G (2005) Molecular dynamics simulations of Alzheimer's beta-amyloid protofilaments.J Mol Biol 353: 804-821
[12] Takeda T, Klimov DK (2009) Replica exchange simulations of the thermodynamics of Abeta fibril growth. Biophys J 96: 442-452
[13] Takeda T, Klimov DK (2009) Interpeptide interactions induce helix to strand structural transition in Abeta peptides. Proteins 77: 1-13
[14] Favrin G, Irback A, Mohanty S. (2004) Oligomerization of amyloid Aβ 16-22 peptides using hydrogen bonds and hydrophobicity forces. Biophys J 87: 3657-3664
[15] Klimov DK, Straub JE, Thirumalai D (2004) Aqueous urea solution destabilizes A β 16-22 oligomers. Proc Natl Acad Sci USA 101: 14760-14765
[16] Ajloo D, Sangian M, Ghadamghahi M, Evini M, Sabouri AA (2013) Effect of two imidazolium derivatives of ionic liquids on the structure and activity of adenosine deaminase. Int J Biol Macromol 55: 47-61
[17] Ajloo D, Ghalehaghababaie S, Mahmoodabadi N (2013) Molecular Dynamics Studies on the Denaturation of Polyalanine in the Presence of Guanidinium Chloride at Low Concentration. Phys Chem Res 1:152-165
[18] Nandi S, Bagchi MC (2010) 3D-QSAR and molecular docking studies of 4-anilino quinazoline derivatives: a rational approach to anticancer drug design. Mol Divers 14:27–38
[19] Ye L, Wu J, Yang J, Chen W, Luo Y, Zhang Y (2015) Design, synthesis and molecular docking analysis of some novel 7-[(quinolin-6-yl)methyl] purines as potential c-Met inhibitors. Med Chem Res. 10.1007/s00044-015-1383-z
[20] Amiri M, Ajloo D (2014) QSAR and docking studies on the diaryltriazine analogs as HIV-1 reverse transcriptase inhibitors chem med res 23: 969-979
[21] Liu X, Chen X, Zhang L, Zhan P, Liu X (2015) 3D-QSAR and docking studies on piperidine-substituted diarylpyrimidine analogues as HIV-1 reverse transcriptase inhibitors. Med Chem Res. 10.1007/s00044-015-1381-1
[22] Eskici G, Gur M (2013) Computational design of new Peptide inhibitors for amyloid Beta (aβ) aggregation in Alzheimer's disease: application of a novel methodology. Plos one 8: e66178
[23] Hoover WG (1985) Canonical dynamics: Equilibrium phase-space distributions. Phys Rev 31:1695-1697
[24] Nosé SA, (1984) A molecular dynamics method for simulations in the canonical esemble. Mol Phys 52:255-268
[25] Parrinello M, Rahman A (1980) Crystal Structure and Pair Potentials: A Molecular-Dynamics Study Phys Rev Lett 45:1196-1199
[26] van Der Spoel E, Lindahl B, Hess G, Groenhof AE, Mark HJ, Berendsen HJC (2005) GROMACS: fast flexible and free. J. Comput. Chem 26: 1701-1718
[27] Van Gunsteren WF, Billeter SR, Eising AA, Hunenberger PH, Kruger P, Mark AE, Scott WRP, Tironi IG (1996) Biomolecular Simulation: The GROMOS96 Manual and User Guide. Verlag der Fachvereine, Zürich, 1-1024
[28] Gerben SR, Lemlul JA, Brown AM, Bevan DR (2014) Synthesis of tetrahydroxybiphenyls and tetrahydroxyterphenyls and their evaluation as amyloid-b aggregation inhibitors. J. Biomol. Struct. Dyn 32: 1817-1832
[29] Berendsen HJC, Postma JPM, van Gunsteren WF, Hermans J (1981) Interaction Models for Water in Relation to Protein Hydration. In Intermolecular Forces; B. Pullman Ed Reidel: Dordecht Holland 331-342
[30] Willard L, Ranjan A, Zhang H, Monzavi H, Boyko RF, Sykes BD, Wishart DS (2003) VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res 31:3316-3319